Please assess the completion status of the following clinical trial:

Trial Title: Effects of SMR Neurofeedback on Insomnia in Patients With Benign Brain Tumors

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosed as primary benign brain tumors such as: meningioma, schwannoma, pituitary tumor, craniopharyngioma according to the results of pathological tissue sections and has completed treatment such as : Surgery, radiation therapy, etc. for at least 7 days.~* Aged from 20 to 65 years old and conscious, able to communicate in Mandarin and Taiwanese.~* Cognitive ability sufficient to complete the questionnaire.~* Complaints of insomnia and ISI score ≥ 8~Exclusion Criteria:~* Long-term shift workers one month before the included study.~* Pregnant women.~* Jet lag workers, such as airline workers.~* Vision, hearing or motor dysfunction is severe enough to affect the participating researcher.~* Preoperative diagnosis of insomnia or long-term use of sleep aids or psychiatric drugs.

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- sensorimotor rhythm neurofeedback training (Type: EXPERIMENTAL): Sensory motor rhythm neurofeedback: The subjects will perform 60 minutes per week for 10 weeks, with a total training time of 600 minutes. The intervention in this trial lasts for 10 weeks (1 time/week), with the goal of improving sensory motor rhythm. Since this training uses visual and auditory feedback, if patients are assigned to this group, they will be ask to wear an EEG cap with 19 electrodes. They can take a relaxed sitting posture and choose animations (e.g., puzzles, mazes, and other feedback content), and then focus on computer screen animation for training, each training time is approximately 60 minutes.
- control group (Type: NO_INTERVENTION): Patient should maintain their usual activity and treatment. Research assistants will weekly contact them to confirm their compliance.

Based on this trial design, predict the completion outcome and termination type (if applicable).